NCT00190996已完成3 期
The Safety and Effectiveness of Duloxetine Compared With Placebo and Its Long-Term Safety and Efficacy in the Treatment of Predominant Stress Urinary Incontinence
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 2,765
- 试验地点
- 2
- 主要终点
- Assess the efficacy of Duloxetine compared with placebo in women with predominant stress urinary incontinence as measured by a reduction in incontinent episode frequency.
研究概览
简要总结
The purposes of this study are to determine whether duloxetine can help subjects with stress urinary incontinence and to see whether the effects of duloxetine can be maintained.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Female diagnosed with stress urinary incontinence
排除标准
- •Currently taking a monoamine oxidase inhibitor
结局指标
主要结局
Assess the efficacy of Duloxetine compared with placebo in women with predominant stress urinary incontinence as measured by a reduction in incontinent episode frequency.
次要结局
- Evaluate the maintenance of effect on IEF in long-term use
- Kings Health Questionnaire
- Patient Global Impression of Improvement Questionnaire
- Safety effects
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.Urinary Incontinence, StressNCT00190814Eli Lilly and Company600
已完成
3 期
Efficacy and Safety of DuloxetineUrinary Stress IncontinenceNCT00190619Eli Lilly and Company100
已完成
3 期
Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)Urinary Incontinence, StressNCT00190827Eli Lilly and Company500
已完成
3 期
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia SyndromeFibromyalgiaNCT01237587Eli Lilly and Company184
已完成
3 期
Duloxetine Versus Placebo in the Treatment of FMSFibromyalgiaNCT00233025Eli Lilly and Company320